Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2007

Heymann JJ, Benson MC, O'Toole KM, Malyszko B, Brody R, Vecchio D, et al. Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer. J Clin Oncol. 2007;25(1):77-84.

Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, et al. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol. 2007;31(5):653-63.

Rheault MN, van Burik J-, Mauer M, Ingulli E, Ferrieri P, Jessurun J, et al. Cat-scratch disease relapse in a kidney transplant recipient. Pediatr Transplant. 2007;11(1):105-9.

Menn KA, Qin L, Fedoriw GD, Gillette ME, McCarthy S. Uterus-like mass: MRI appearance of a very rare entity. J Magn Reson Imaging. 2007;26(1):162-4.

Arora N, Hill C, Hoda SA, Rosenblatt R, Pigalarga R, Tousimis EA. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy. Am J Surg. 2007;194(4):444-9.

M Lensch W, Ince TA. The terminology of teratocarcinomas and teratomas. Nat Biotechnol. 2007;25(11):1211; author reply 1211-2.

Marchionni L, Wilson RF, Marinopoulos SS, Wolff AC, Parmigiani G, Bass EB, et al. Impact of gene expression profiling tests on breast cancer outcomes. Evid Rep Technol Assess (Full Rep). 2007;(160):1-105.

Chaar ME, Chen J, Seshan SV, Jha S, Richardson I, Ledbetter SR, et al. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2007;292(4):F1291-301.

Jacob EK, Edwards WD, Zucker M, D'Cruz C, Seshan SV, Crow FW, et al. Homozygous transthyretin mutation in an African American Male. J Mol Diagn. 2007;9(1):127-31.

Xu Q, Majumder PK, Ross K, Shim Y, Golub TR, Loda M, et al. Identification of prostate cancer modifier pathways using parental strain expression mapping. Proc Natl Acad Sci U S A. 2007;104(45):17771-6.